| __timestamp | Pharming Group N.V. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 4042025 | 305409000 |
| Thursday, January 1, 2015 | 5279557 | 377080000 |
| Friday, January 1, 2016 | 8073913 | 432829000 |
| Sunday, January 1, 2017 | 44864073 | 496079000 |
| Monday, January 1, 2018 | 53488904 | 557616000 |
| Tuesday, January 1, 2019 | 65896361 | 658498000 |
| Wednesday, January 1, 2020 | 69968267 | 770456000 |
| Friday, January 1, 2021 | 92047281 | 840100000 |
| Saturday, January 1, 2022 | 131819000 | 944700000 |
| Sunday, January 1, 2023 | 87501000 | 1136600000 |
| Monday, January 1, 2024 | 1464300000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, understanding financial trends is crucial. Over the past decade, Vertex Pharmaceuticals Incorporated has consistently outpaced Pharming Group N.V. in Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Vertex's SG&A expenses surged by approximately 270%, peaking in 2023 with a staggering 1.14 billion USD. In contrast, Pharming Group's expenses grew by about 2,065%, reaching 131.8 million USD in 2022 before a slight dip in 2023.
This trend highlights Vertex's aggressive investment in administrative and sales functions, likely fueling its market dominance. Meanwhile, Pharming's more modest growth in SG&A expenses suggests a different strategic focus, possibly prioritizing cost efficiency. These insights provide a window into the strategic priorities of these pharmaceutical giants, offering valuable lessons for investors and industry analysts alike.
Comparing SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Takeda Pharmaceutical Company Limited Trends and Insights
Research and Development: Comparing Key Metrics for Vertex Pharmaceuticals Incorporated and Pharming Group N.V.
Vertex Pharmaceuticals Incorporated and Cytokinetics, Incorporated: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Rhythm Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Veracyte, Inc.
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Insmed Incorporated and Pharming Group N.V.
Ascendis Pharma A/S and Pharming Group N.V.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Pharming Group N.V. vs Veracyte, Inc.
Pharming Group N.V. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Pharming Group N.V. and Ligand Pharmaceuticals Incorporated
Comparing SG&A Expenses: Pharming Group N.V. vs Dynavax Technologies Corporation Trends and Insights